SCIG Subcutaneous Immune Globulin Products
Immune globulin is made from pooled plasma collected from thousands of donors and treated to remove contaminants to ensure product safety and integrity. Containing antibodies against a broad spectrum of bacteria and viruses, SCIG is administered subcutaneously and is approved to treat primary immune deficiencies.
Nufactor carries the following F.D.A.-approved SCIG products:
Product
Manufacturer
FDA-Approved Indication
SUBCUTANEOUS IMMUNE GLOBULIN (SCIG)
Product: CUVITRU™
Manufacturer: Takeda
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: CUTAQUIG®
Manufacturer: Octapharma
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: GAMMAGARD LIQUID
Manufacturer: Shire
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: GAMMAKED™
Manufacturer: Kedrion
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: GAMUNEX®-C
Manufacturer: Grifols
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: Hizentra®
Manufacturer: CSL Behring
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: HYQVIA®
Manufacturer: Shire
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: XEMBIFY®
Manufacturer: Grifols
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
